Annual report pursuant to Section 13 and 15(d)

12. Business Combinations (Details - Proforma)

v3.7.0.1
12. Business Combinations (Details - Proforma)
 12 Months Ended
Dec. 31, 2015
USD ($)
$ / shares
shares
Net Revenues $ 18,818,038
Operating Expenses 68,739,012
Income (Loss) from operations (48,689,007)
Other income (expense) 431,215
Income (Loss) before income taxes (48,257,792)
Provision for income taxes (9,297,253)
Net income (loss) attributable to Rennova Health (38,960,539)
Preferred stock dividends 0
Net income (loss) attributable to Rennova Health common shareholders $ (38,960,539)
Net income (loss) per common share: Basic | $ / shares $ (87.88)
Net income (loss) per common share: Diluted | $ / shares $ (87.88)
Weighted average number of common shares outstanding during the period: Basic | shares 443,322
Weighted average number of common shares outstanding during the period: Diluted | shares 443,322
Pro Forma Adjustments [Member]  
Net Revenues $ 0
Operating Expenses 0
Income (Loss) from operations 0
Other income (expense) 0
Income (Loss) before income taxes 0
Provision for income taxes 0
Net income (loss) attributable to Rennova Health 0
Preferred stock dividends (1,627,188)
Net income (loss) attributable to Rennova Health common shareholders 1,627,188
Rennova Health, Inc. [Member]  
Net Revenues 18,393,038
Operating Expenses 63,858,012
Income (Loss) from operations (45,464,974)
Other income (expense) 474,215
Income (Loss) before income taxes (44,990,759)
Provision for income taxes (9,028,253)
Net income (loss) attributable to Rennova Health (35,962,506)
Preferred stock dividends 1,627,188
Net income (loss) attributable to Rennova Health common shareholders $ (37,589,694)
Net income (loss) per common share: Basic | $ / shares $ (90.46)
Net income (loss) per common share: Diluted | $ / shares $ (90.46)
Weighted average number of common shares outstanding during the period: Basic | shares 415,517
Weighted average number of common shares outstanding during the period: Diluted | shares 415,517
CollabRx, Inc. [Member]  
Net Revenues $ 425,000
Operating Expenses 4,881,000
Income (Loss) from operations (4,456,000)
Other income (expense) (43,000)
Income (Loss) before income taxes (4,499,000)
Provision for income taxes (269,000)
Net income (loss) attributable to Rennova Health (4,230,000)
Preferred stock dividends 0
Net income (loss) attributable to Rennova Health common shareholders $ (4,230,000)